Free Trial

Sagespring Wealth Partners LLC Sells 1,381 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

UnitedHealth Group logo with Medical background

Sagespring Wealth Partners LLC lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 7.9% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 16,133 shares of the healthcare conglomerate's stock after selling 1,381 shares during the quarter. Sagespring Wealth Partners LLC's holdings in UnitedHealth Group were worth $8,450,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the business. Precedent Wealth Partners LLC raised its stake in shares of UnitedHealth Group by 31.8% during the 1st quarter. Precedent Wealth Partners LLC now owns 2,370 shares of the healthcare conglomerate's stock worth $1,241,000 after acquiring an additional 572 shares in the last quarter. Great Lakes Retirement Inc. grew its position in UnitedHealth Group by 81.7% during the 1st quarter. Great Lakes Retirement Inc. now owns 23,707 shares of the healthcare conglomerate's stock worth $12,416,000 after purchasing an additional 10,660 shares during the last quarter. Adero Partners LLC grew its position in UnitedHealth Group by 21.3% during the 1st quarter. Adero Partners LLC now owns 1,470 shares of the healthcare conglomerate's stock worth $770,000 after purchasing an additional 258 shares during the last quarter. BDF Gestion grew its position in UnitedHealth Group by 13.0% during the 1st quarter. BDF Gestion now owns 33,970 shares of the healthcare conglomerate's stock worth $17,792,000 after purchasing an additional 3,920 shares during the last quarter. Finally, Sowell Financial Services LLC grew its position in UnitedHealth Group by 4.1% during the 1st quarter. Sowell Financial Services LLC now owns 11,480 shares of the healthcare conglomerate's stock worth $6,013,000 after purchasing an additional 447 shares during the last quarter. Institutional investors own 87.86% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on UNH. TD Cowen downgraded shares of UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price objective on the stock. in a report on Monday, May 19th. Oppenheimer dropped their price objective on shares of UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating on the stock in a report on Wednesday, May 14th. Morgan Stanley dropped their price objective on shares of UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating on the stock in a report on Wednesday, May 14th. HSBC reissued a "reduce" rating and set a $270.00 price target (down from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. Finally, Baird R W downgraded shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Wednesday, June 11th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have assigned a buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group presently has an average rating of "Moderate Buy" and a consensus price target of $426.52.

Read Our Latest Research Report on UNH

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the business's stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the transaction, the chief executive officer now owns 10,398 shares in the company, valued at $3,171,390. The trade was a 5.36% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CEO Stephen J. Hemsley purchased 86,700 shares of the company's stock in a transaction on Friday, May 16th. The stock was acquired at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the purchase, the chief executive officer now owns 679,493 shares of the company's stock, valued at approximately $196,081,295.01. This represents a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last quarter, insiders purchased 109,408 shares of company stock worth $31,607,768. Insiders own 0.28% of the company's stock.

UnitedHealth Group Stock Down 1.6%

Shares of NYSE UNH opened at $313.39 on Monday. The company has a market capitalization of $284.28 billion, a P/E ratio of 20.22, a P/E/G ratio of 1.37 and a beta of 0.44. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The company has a 50 day simple moving average of $386.66 and a 200-day simple moving average of $472.32. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to analysts' expectations of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period in the previous year, the firm posted $6.91 EPS. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be issued a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.82%. The ex-dividend date of this dividend is Monday, June 16th. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio (DPR) is 37.02%.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Recommended Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Oil Spikes Amid Rising Warfare: 3 Stocks to Watch Now
Palantir at All-Time Highs: Take Profits or Hold the Line?
3 Tech Stocks Insiders Are Buying: Speculative Plays for June

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines